Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-3 of 3
Keywords: CD34
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
CD34-Positive Blast Count and p53 Expression in Bone Marrow Biopsies of Patients with Low-Risk Myelodysplastic Syndromes: Potential Predictive Tools of Response to Erythropoietin Stimulating Agents
Available to PurchaseFrancesca Boggio, Alessandro Del Gobbo, Marco Barella, Giorgio Croci, Ramona Cassin, Gianluigi Reda, Loredana Pettine, Laura Bandiera, Emanuela Bonoldi, Marta Riva, Umberto Gianelli
Journal:
Pathobiology
Pathobiology (2021) 88 (3): 242–250.
Published Online: 15 February 2021
... treated with ESAs. Results: In our series, substantial morphological overlap was found between responder and nonresponder patients. On the contrary, patients with a percentage of CD34-positive blasts >3% or with p53 protein expression <1% responded with a significantly higher frequency to ESAs...
Journal Articles
Expression of CD34 in Pulmonary Endothelial Cells in vivo 1
Available to Purchase
Journal:
Pathobiology
Pathobiology (2002) 70 (1): 11–17.
Published Online: 04 November 2002
... by physiological factors (e.g. age, sex) or pathological factors (e.g. pulmonary hypertension) on EC have not been ascertained up to now. Methods: In order to determine the influence of pulmonary hypertension (PH), age and sex on EC, we localized the expression of the endothelial marker CD34 immunohistologically...
Journal Articles
Comparative Analysis of the Reactivity of Human Umbilical Vein Endothelial Cells in Organ and Monolayer Culture
Available to Purchase
Journal:
Pathobiology
Pathobiology (1999) 67 (2): 99–107.
Published Online: 22 February 1999
.... Endothelial cell HUVEC Organ culture Adhesion molecule CD34 Endothelial nitric oxide synthase Fibrinolysis Tissue plasminogen activator Plasminogen activator inhibitor Tumor necrosis factor-α Original Paper Pathobiology 1999;67:99 107 Received: July 17, 1998 Accepted: August 5, 1998 Comparative...